Jules Harris, M.D., F.A.C.P.; Raymond Alexanian, M.D.; Evan M. Hersh, M.D.; Philip Migliore, M.D.
This content is PDF only. Please click on the PDF icon to access.
Twenty-three patients (11 men with age range of 56 to 81 years—median, 62; 12 women with age range of 39 to 78 years—median, 62) with multiple myeloma were immunized with 5 mg keyhole limpet hemocyanin given subcutaneously. The distribution of myeloma protein types was as follows: gamma GK, 8 patients; gamma G L, 6; gamma A K, 2; gamma A L, 3; Bence Jones protein only: K, 3 and L, 1. Humoral antibody formation of 7S and 19S type, in vivo delayed hypersensitivity, and in vitro lymphocyte transformation were studied serially. Nine of 11 patients studied developed normal diameter skin
Learn more about subscription options.
Register Now for a free account.
Harris J, Alexanian R, Hersh EM, Migliore P. Abnormal Immune Response to Keyhole Limpet Hemocyanin (KLH) in Patients with Multiple Myeloma.. Ann Intern Med. 1969;70:1084. doi: 10.7326/0003-4819-70-5-1084_1
Download citation file:
Published: Ann Intern Med. 1969;70(5):1084.
Hematology/Oncology, Multiple Myeloma.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only